TERESA SIROIS: Open Payments
NPI 1396779757 · TOPSHAM, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$722 in 26 payments from 14 companies in 2025. Trend: 2023 $359 · 2024 $214 · 2025 $722
Food & beverage: $722
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $173 |
| ABBVIE INC. | 6 | $148 |
| E.R. Squibb & Sons, L.L.C. | 2 | $69 |
| Incyte Corporation | 2 | $54 |
| Celgene Corporation | 1 | $35 |
| Daiichi Sankyo Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Janssen Biotech, Inc. | 1 | $30 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $29 |
| Caris MPI, Inc. | 1 | $27 |
Products named: EPKINLY, AIRSUPRA, OPDIVO, TAGRISSO, Enhertu, REBLOZYL, NINLARO, MONJUVI.
Industry payments across ME — which companies pay providers there.
